Fangting Wu
Impact in
- Cancer Research top 0.5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Molecular Biology top 5%
- Circular RNAs in diseases
- RNA modifications and cancer
- RNA Research and Splicing
- RNA Interference and Gene Delivery
- CRISPR and Genetic Engineering
- Advanced biosensing and bioanalysis techniques
Papers in
-
- RNA modifications and cancer 4
- CRISPR and Genetic Engineering 3
- Epigenetics and DNA Methylation 2
- RNA Research and Splicing 2
- Circular RNAs in diseases 2
-
- Cancer-related molecular mechanisms research 7
- MicroRNA in disease regulation 4
- Co-authors
- Hailong Wu (2 shared papers)Yin‐Yuan Mo (7 shared papers)Yin-Yuan Mo (2 shared papers)Daotai Nie (1 shared paper)Shijie Sheng (1 shared paper)Jianguo Huang (5 shared papers)Nanjiang Zhou (4 shared papers)Shoumin Zhu (1 shared paper)
- Journals
- Nature Communications (3 papers)Frontiers in bioscience (2 papers)Nucleic Acids Research (2 papers)Molecular Cancer Therapeutics (1 paper)Scientific Reports (1 paper)
- Partner nations
- United StatesChinaItaly
In The Last Decade
Fangting Wu
17 papers receiving 2.8k citations
Hit Papers
Peers
Comparison fields: 5 of 101
- Cancer Research 2.0k
- Molecular Biology 2.5k
- Oncology 276
- Aging 16
- Business and International Management 12
Countries citing papers authored by Fangting Wu
This map shows the geographic impact of Fangting Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fangting Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fangting Wu more than expected).
Fields of papers citing papers by Fangting Wu
This network shows the impact of papers produced by Fangting Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fangting Wu. The network helps show where Fangting Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside Fangting Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | MicroRNA-21 targets tumor suppressor genes in invasion and metastasis Hit paper breakdown → | 2008 | 894 |
| 2 | p53 represses c-Myc through induction of the tumor suppressor miR-145 Hit paper breakdown → | 2009 | 691 |
| 3 | 2013 | 333 | |
| 4 | 2014 | 200 | |
| 5 | 2017 | 191 | |
| 6 | 2009 | 165 | |
| 7 | 2009 | 101 | |
| 8 | 2017 | 90 | |
| 9 | 2016 | 58 | |
| 10 | 2016 | 42 | |
| 11 | 2007 | 38 | |
| 12 | 2007 | 26 | |
| 13 | 2006 | 19 | |
| 14 | 2023 | 10 | |
| 15 | 2025 | 5 | |
| 16 | 2014 | 4 | |
| 17 | 2010 | 1 | |
| 18 | 2025 | 0 | |
| 19 | 2025 | 0 |
About Fangting Wu
Fangting Wu is a scholar working on Molecular Biology, Cancer Research, Genetics, Immunology and Pollution, having authored 19 papers that have together received 2.9k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (7 papers), MicroRNA in disease regulation (4 papers), RNA modifications and cancer (4 papers), CRISPR and Genetic Engineering (3 papers), Epigenetics and DNA Methylation (2 papers), RNA Research and Splicing (2 papers), Circular RNAs in diseases (2 papers) and Inflammatory Bowel Disease (2 papers). The work is most often cited by research in Cancer Research (2.0k citations), Molecular Biology (2.5k citations), Oncology (276 citations), Aging (16 citations) and Business and International Management (12 citations). Fangting Wu has collaborated with scholars based in United States, China and Italy. Frequent co-authors include Hailong Wu, Yin‐Yuan Mo, Yin-Yuan Mo, Daotai Nie, Shijie Sheng, Jianguo Huang, Nanjiang Zhou, Shoumin Zhu, Randolph C. Elble and Vijay Walia. Their work appears in journals such as Nature Communications, Frontiers in bioscience, Nucleic Acids Research, Molecular Cancer Therapeutics and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.